Health-monitoring apps can help people manage chronic diseases or stay on track with fitness goals, using nothing more than a smartphone. However, these apps can be slow and energy-inefficient because the vast machine-learning...
Nine months after its introduction in the U.S., Eisai and Biogen’s Alzheimer’s drug Leqembi is encountering significant resistance in its widespread adoption, largely due to skepticism among some doctors about the efficacy of treating...